fbpx

Cannabis

2019 weed wrap: The end of the cannabis cycle of cannabis cycles

Like the old Twilight Zone episode where helpful aliens leave behind a book called ‘To Serve Man’, only for us to find out later it’s a cookbook, investors have been welcomed and fattened up nicely by alpha predators as they unwittingly await their slaughter, not realizing that, they’re at the predator’s table because they’re the main course.

Read More »
Beleave-Kannabis.png

Equity.Guru podcast: Mistakes were made – Jeanette VanderMarel’s happy goodbye to Beleave (BE.C)

With the twitter announcement this morning that Jeanette had “happily” left the position of CEO at Beleave Kannabis (BE.C), Equity.Guru’s own Chris Parry was chomping at the bit to find out just what “happily” meant for the market and investors. Twenty minutes after making her announcement, VanderMarel phoned up Chris to give him the skinny on her decision as well as some explanations for past actions which gave both industry players and investors some pause.

Read More »

Deathwatch: MedMen (MMEN.C) is cutting out everything but the cancer that is killing it

If you’ve been around this joint for a while, you’ll have seen us arguing folks would be silly to invest in MedMen (MMEN.C) if hanging on to your money is a thing you aspire to do.

That’s not because we have a hate on for the dude-bros running the show, or because they’re not a client, or because we’re short sellers, or any of the other 50 or so reasons MedMen homers have thrown at us over the last few years as a rationale for us not seeing the company in the same rose-coloured way they do.

It’s because MedMen is, and has always been, shit.

Read More »

Equity Guru Podcasts